3D Doppler ultrasound helps identify breast cancer

Three-dimensional (3D) power Doppler ultrasound helps radiologists distinguish between malignant and benign breast masses, according to a new study published in the November issue of Radiology.

“Using 3D scans promises greater accuracy due to more consistent sampling over the entire tumor,” said the study’s lead author Gerald L. LeCarpentier, PhD, assistant professor in the department of radiology at University of Michigan in Ann Arbor. “Our study shows that 3D power Doppler ultrasound may be useful in the evaluation of some breast masses.”

Malignant breast masses often exhibit increased blood flow compared to normal tissue or benign masses. Using 3D power Doppler ultrasound, the researchers said that radiologists are able to detect vessels with higher flow speeds, which likely indicate cancer.

LeCarpentier and colleagues studied 78 women between the ages of 26 and 70, who were scheduled for biopsy of a suspicious breast mass. Each of the women underwent a 3D Doppler ultrasound exam followed by core or excisional biopsy of the breast.

The results showed that 3D power Doppler ultrasound was highly accurate in identifying malignant breast tumors, according to the researchers. When combined with age-based assessment and gray scale visual analysis, the investigators found that 3D Doppler showed a sensitivity of 100 percent in identifying cancerous tumors and a specificity of 86 percent in excluding benign tumors.

“Using speed-weighted 3D power Doppler ultrasound, higher flow velocities in the malignant tumor-feeding vessels may be detected, whereas vessels with slower flow velocities in surrounding benign masses may be excluded," LeCarpentier said.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.